Title
Category
Credits
Event date
Cost
- On-Demand
- 1.20 ABN
- 1.00 ACPE Pharmacy
$25.00
Chronic coronary disease (CCD), formerly known as "stable ischemic heart disease," encompasses a diverse range of conditions, including both obstructive and nonobstructive coronary artery disease (CAD), with or without a history of myocardial infarction (MI) or revascularization. It also includes ischemic heart disease diagnosed solely through noninvasive testing and chronic angina syndromes arising from various underlying causes. Approximately 20 million people in the United States live with CCD, and it remains a leading cause of death.
- On-Demand
- 2.00 ACPE Pharmacy
- 2.00 ACPE Technician
$0.00
Medicare is a national health insurance program run by the federal government of the United States available to adults aged 65 or older and those younger with certain disease states and disabilities. With over 66 million participants enrolled, it is one of the largest health insurance programs in the country and consists of four major parts: A, B, C, and D.
- On-Demand
- 1.00 ACPE Pharmacy
$25.00
This session will explore the impact of legislative changes and accreditation standards on inclusive excellence initiatives in pharmacy education. Participants will learn about the importance of cultural competence, the challenges to achieving inclusive excellence, and the benefits of inclusive practices. Discover best practices for preceptors to promote an inclusive and equitable learning environment in both classroom and clinical settings.
- Substance Use Disorders in Alabama (SUDA)
- On-Demand
- COACH
- 1.20 ABN
- 1.00 ABSWE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
$0.00
A evaluation of non-traditional, legal, substances that are being misused and abused in the community to achieve legal intoxications.
- Substance Use Disorders in Alabama (SUDA)
- On-Demand
- COACH
- 1.20 ABN
- 1.00 ABSWE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will review National and AL data on OUD and use pattern trends. We will discuss risk factors, behavioral clues, and DSM criteria. Epidemiology and prevalence will be discussed. The changing opioid crisis will be discussed with increased emphasis on illicit synthetic opioid use rather than the prescription opioid use driving the current crisis. We will discuss impact of medical cannabis use on patients prescribed opioids for various conditions.
- Substance Use Disorders in Alabama (SUDA)
- On-Demand
- COACH
- 1.20 ABN
- 1.00 ABSWE
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
$0.00
National and Alabama use patterns & trends will be discussed including data from treatment admissions. Risk factors and DSM criteria along with prevalence and epidemiology will be reviewed. A description of available products and relative potency. We will review heavily utilized alternatives like delta-8 and/or delta-10 along with their legal status. We will review in detail the new AL Medical Cannabis Use from the Alabama Compassion Act in 2021 that will be implemented starting 9/1/22.
Pages
- « first
- ‹ previous
- 1
- 2
- 3